Dr David M Sheinbein, MD | |
969 N Mason Rd, Div Im Dermatology, Ste 220, Saint Louis, MO 63141-6282 | |
(314) 273-3376 | |
(888) 682-0525 |
Full Name | Dr David M Sheinbein |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 29 Years |
Location | 969 N Mason Rd, Saint Louis, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568489193 | NPI | - | NPPES |
203940903 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 108407 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Barnes-jewish West County Hospital | Creve coeur, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Washington University | 9830008770 | 2506 |
News Archive
Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.
Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.
Researchers have succeeded in revealing the arsenal used by protozoans of the genus Leishmania in human cells to make leishmaniasis more severe, especially in cases of the mucocutaneous variety of the disease, which can cause deformations in patients.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."
› Verified 8 days ago
Entity Name | Washington University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.
Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.
Researchers have succeeded in revealing the arsenal used by protozoans of the genus Leishmania in human cells to make leishmaniasis more severe, especially in cases of the mucocutaneous variety of the disease, which can cause deformations in patients.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David M Sheinbein, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 273-3376 | Dr David M Sheinbein, MD 969 N Mason Rd, Div Im Dermatology, Ste 220, Saint Louis, MO 63141-6282 Ph: (314) 273-3376 |
News Archive
Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.
Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.
Researchers have succeeded in revealing the arsenal used by protozoans of the genus Leishmania in human cells to make leishmaniasis more severe, especially in cases of the mucocutaneous variety of the disease, which can cause deformations in patients.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."
› Verified 8 days ago
Dr. Caroline M Mann, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd, Div Im Dermatology, Ste 220, Saint Louis, MO 63141 Phone: 314-273-3376 Fax: 888-682-0525 | |
Dr. Eva A. Hurst, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd Ste 200, Ste 200, Saint Louis, MO 63141 Phone: 314-996-8810 Fax: 314-996-8775 | |
Shane A Grace, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12855 N 40 Dr Ste 180, Saint Louis, MO 63141 Phone: 314-878-5599 Fax: 314-392-4290 | |
Dr. Lee S Portnoff, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd, Ste 310a, Saint Louis, MO 63131 Phone: 314-993-2909 | |
Aibing Mary Guo, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1225 S Grand Blvd Fl 3, Saint Louis, MO 63104 Phone: 314-977-3400 Fax: 314-977-7613 | |
Dr. Amy C Musiek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, MO 63108 Phone: 314-273-3376 Fax: 888-665-8309 | |
Dr. Gillian Meade Heinecke, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1755 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-256-3430 Fax: 314-256-3431 |